Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An update from Race Oncology Ltd. ( (AU:RAC) ) is now available.
Race Oncology Ltd announced the cessation of 558,040 securities due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This cessation may impact the company’s capital structure and could have implications for its stakeholders, reflecting on its operational and strategic positioning within the biotechnology sector.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the biotechnology industry, focusing on the development and commercialization of cancer therapies.
Average Trading Volume: 134,324
Technical Sentiment Signal: Sell
Current Market Cap: A$222.4M
For a thorough assessment of RAC stock, go to TipRanks’ Stock Analysis page.